{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:22:18Z","timestamp":1786123338659,"version":"build-2736575974"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1213\/ane.0b013e3181605a15","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T01:52:07Z","timestamp":1236217927000},"page":"463-470","source":"Crossref","is-referenced-by-count":35,"title":["Pharmacological Characterization of Noroxymorphone as a New Opioid for Spinal Analgesia"],"prefix":"10.1213","volume":"106","author":[{"given":"Kim K.","family":"Lemberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti O.","family":"Siiskonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa K.","family":"Kontinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari T.","family":"Yli-Kauhaluoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eija A.","family":"Kalso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210902","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0022-5347(24)06114-7","article-title":"Isolation and identification of urinary metabolites of oxycodone in rabbits.","volume":"7","author":"Ishida","year":"1979","journal-title":"Drug Metab Dispos"},{"key":"R2-17-20210902","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jps.2600680441","article-title":"Determination of oxycodone in plasma and identification of a major metabolite.","volume":"68","author":"Weinstein","year":"1979","journal-title":"J Pharm Sci"},{"key":"R3-17-20210902","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1248\/bpb1978.5.134","article-title":"A novel metabolite of oxycodone in the urine of rabbits.","volume":"5","author":"Ishida","year":"1982","journal-title":"J Pharmacobio Dyn"},{"key":"R4-17-20210902","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0090-9556(25)08048-1","article-title":"Oxymorphone metabolism and urinary excretion in human, rat, guinea pig, rabbit, and dog.","volume":"11","author":"Cone","year":"1983","journal-title":"Drug Metab Dispos"},{"key":"R5-17-20210902","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/clpt.1993.43","article-title":"Inhibition by fluoxetine of cytochrome P450 2D6 activity.","volume":"53","author":"Otton","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"R6-17-20210902","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1124\/dmd.32.4.447","article-title":"Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes.","volume":"32","author":"Lalovic","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"R7-17-20210902","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2125.1992.tb04090.x","article-title":"The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects.","volume":"33","author":"Poyhia","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"R8-17-20210902","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0952-8180(95)00092-5","article-title":"The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation.","volume":"8","author":"Kirvela","year":"1996","journal-title":"J Clin Anesth"},{"key":"R9-17-20210902","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clpt.2006.01.009","article-title":"Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites.","volume":"79","author":"Lalovic","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"R10-17-20210902","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/jpet.103.058602","article-title":"Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors.","volume":"308","author":"Thompson","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"R11-17-20210902","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0022-3565(25)24481-0","article-title":"Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine.","volume":"244","author":"Yaksh","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"R12-17-20210902","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals.","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"key":"R13-17-20210902","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0031-9384(76)90029-9","article-title":"Chronic catheterization of the spinal subarachnoid space.","volume":"17","author":"Yaksh","year":"1976","journal-title":"Physiol Behav"},{"key":"R14-17-20210902","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","article-title":"Carrageenan-induced edema in hind paw of the rat as an assay for antiiflammatory drugs.","volume":"111","author":"Winter","year":"1962","journal-title":"Proc Soc Exp Biol Med"},{"key":"R15-17-20210902","doi-asserted-by":"crossref","first-page":"8156","DOI":"10.1523\/JNEUROSCI.15-12-08156.1995","article-title":"Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation.","volume":"15","author":"Ji","year":"1995","journal-title":"J Neurosci"},{"key":"R16-17-20210902","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.neuroscience.2004.06.086","article-title":"Rapid upregulation of mu opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction.","volume":"129","author":"Puehler","year":"2004","journal-title":"Neuroscience"},{"key":"R17-17-20210902","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00000542-199901000-00029","article-title":"Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist\u2013loperamide.","volume":"90","author":"Nozaki-Taguchi","year":"1999","journal-title":"Anesthesiology"},{"key":"R18-17-20210902","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/jpet.104.077792","article-title":"Nociceptive sensitivity and opioid antinociception and antihyperalgesia in Freund\u2019s adjuvant-induced arthritic male and female rats.","volume":"313","author":"Cook","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R19-17-20210902","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S0022-3565(25)24051-4","article-title":"Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.","volume":"271","author":"Emmerson","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"R20-17-20210902","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00000542-199707000-00017","article-title":"Assessment of the potency and intrinsic activity of systemic versus intrathecal opioids in rats.","volume":"87","author":"Abram","year":"1997","journal-title":"Anesthesiology"},{"key":"R21-17-20210902","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pbb.2004.12.002","article-title":"A preclinical comparison between different opioids: antinociceptive versus adverse effects.","volume":"80","author":"Meert","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"R22-17-20210902","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00000542-199601000-00012","article-title":"Comparison of the spinal actions of the mu-opioid remifentanil with alfentanil and morphine in the rat.","volume":"84","author":"Buerkle","year":"1996","journal-title":"Anesthesiology"},{"key":"R23-17-20210902","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/00000542-200003000-00018","article-title":"Comparative spinal distribution and clearance kinetics of intrathecally administered morphine, fentanyl, alfentanil, and sufentanil.","volume":"92","author":"Ummenhofer","year":"2000","journal-title":"Anesthesiology"},{"key":"R24-17-20210902","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00000542-198601000-00009","article-title":"Studies of the pharmacology and pathology of intrathecally administered 4-anilinopiperidine analogues and morphine in the rat and cat.","volume":"64","author":"Yaksh","year":"1986","journal-title":"Anesthesiology"},{"key":"R25-17-20210902","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0304-3959(89)90118-8","article-title":"Intrathecal opioids, potency and lipophilicity.","volume":"36","author":"McQuay","year":"1989","journal-title":"Pain"},{"key":"R26-17-20210902","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0304-3959(90)91166-G","article-title":"Intrathecal etorphine, fentanyl and buprenorphine on spinal nociceptive neurones in the rat.","volume":"42","author":"Dickenson","year":"1990","journal-title":"Pain"},{"key":"R27-17-20210902","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/00000542-200610000-00027","article-title":"Antinociception by spinal and systemic oxycodone: why does the route make a difference?: in vitro and in vivo studies in rats.","volume":"105","author":"Lemberg","year":"2006","journal-title":"Anesthesiology"},{"key":"R28-17-20210902","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0773.1994.tb01068.x","article-title":"Liposolubility and protein binding of oxycodone in vitro.","volume":"74","author":"Poyhia","year":"1994","journal-title":"Pharmacol Toxicol"},{"key":"R29-17-20210902","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1021\/jm0506219","article-title":"Presentation of a structurally diverse and commercially available drug data set for correlation and benchmarking studies.","volume":"49","author":"Skold","year":"2006","journal-title":"J Med Chem"},{"key":"R30-17-20210902","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0952-8180(96)00212-7","article-title":"Comparison of epidural morphine and oxycodone for pain after abdominal surgery.","volume":"9","author":"Backlund","year":"1997","journal-title":"J Clin Anesth"},{"key":"R31-17-20210902","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/bja\/aeh218","article-title":"Epidural oxycodone or morphine following gynaecological surgery.","volume":"93","author":"Yanagidate","year":"2004","journal-title":"Br J Anaesth"},{"key":"R32-17-20210902","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0304-3959(90)91131-2","article-title":"Influence of polarity on dose-response relationships of intrathecal opioids in rats.","volume":"40","author":"Plummer","year":"1990","journal-title":"Pain"},{"key":"R33-17-20210902","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-0773.1992.tb00441.x","article-title":"Antinociceptive effects and central nervous system depression caused by oxycodone and morphine in rats.","volume":"70","author":"Poyhia","year":"1992","journal-title":"Pharmacol Toxicol"},{"key":"R34-17-20210902","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0024-3205(99)00148-4","article-title":"Opioid binding profiles of new hydrazone, oxime, carbazone and semicarbazone derivatives of 14-alkoxymorphinans.","volume":"64","author":"Monory","year":"1999","journal-title":"Life Sci"},{"key":"R35-17-20210902","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/0024-3205(91)90150-A","article-title":"Mu receptor binding of some commonly used opioids and their metabolites.","volume":"48","author":"Chen","year":"1991","journal-title":"Life Sci"},{"key":"R36-17-20210902","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1124\/dmd.106.009746","article-title":"In vivo blood-brain barrier transport of oxycodone in the rat-indications for active influx and implications for PK\/PD.","volume":"34","author":"Bostrom","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"R37-17-20210902","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","article-title":"Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.","volume":"86","author":"Cordon-Cardo","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"R38-17-20210902","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/00000542-200005000-00030","article-title":"Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein.","volume":"92","author":"Thompson","year":"2000","journal-title":"Anesthesiology"},{"key":"R39-17-20210902","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jps.20327","article-title":"Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833.","volume":"94","author":"Bostrom","year":"2005","journal-title":"J Pharm Sci"},{"key":"R40-17-20210902","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1002\/jps.20893","article-title":"Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel\u2019s tissue distribution in Sprague-Dawley rats.","volume":"96","author":"Hassan","year":"2007","journal-title":"J Pharm Sci"},{"key":"R41-17-20210902","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00000542-198605000-00008","article-title":"High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications.","volume":"64","author":"Yaksh","year":"1986","journal-title":"Anesthesiology"},{"key":"R42-17-20210902","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0006-8993(81)90176-1","article-title":"Intrathecal high dose morphine produces hyperalgesia in the rat.","volume":"209","author":"Woolf","year":"1981","journal-title":"Brain Res"},{"key":"R43-17-20210902","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0006-8993(96)00319-8","article-title":"Spinally-mediated behavioural responses evoked by intrathecal high-dose morphine: possible involvement of substance P in the mouse spinal cord.","volume":"724","author":"Sakurada","year":"1996","journal-title":"Brain Res"},{"key":"R44-17-20210902","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0169-328X(01)00332-1","article-title":"Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.","volume":"98","author":"Sakurada","year":"2002","journal-title":"Brain Res Mol Brain Res"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ane.0b013e3181605a15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:25:02Z","timestamp":1786112702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-200802000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3181605a15","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}